Comment from Cruelty Free International

Please find attached Cruelty Free International's comments on the FDA Draft Guidance: "Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products". We appreciate the opportunity to provide our input.